Home/HasenTech/Katherine L. Knight, PhD

KL

Katherine L. Knight, PhD

Co-Founder

Therapeutic Areas

Graft-versus-Host Disease (GvHD)Inflammatory Disease Autoimmune Disease

HasenTech Pipeline

Drug	Indication	Phase
HT-01	Prevention of Graft-versus-Host Disease (GvHD) post bone marrow transplant	Pre-clinical

Leadership Team at HasenTech

Barbara A. Osborne, PhD

Richard A. Goldsby, PhD

Lisa M. Minter, PhD

Member, Board of Directors

Patrick J. Stiff, MD

Member, Board of Directors

View full HasenTech profile